Associated Papers
Homologous recombination deficiency among patients with germline or somatic non-BRCA1/2 homologous recombination repair gene variations.
Li Y et al.
Npj Precision Oncology, 2025
Association Between TP53 Mutations and Platinum Resistance in a Cohort of High-Grade Serous Ovarian Cancer Patients: Novel Implications for Personalized Therapeutics.
Madeddu C et al.
International Journal of Molecular Sciences, 2025
Genomic landscape of early-stage prostate adenocarcinoma in Mexican patients: an exploratory study.
Cerrato-Izaguirre D et al.
Discover Oncology, 2024
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma.
Öfverholm I et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Palafox M et al.
Nature Communications, 2022
Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome.
Dos Santos W et al.
Cancers, 2022
Rare coding variants in DNA damage repair genes associated with timing of natural menopause.
Ward LD et al.
Hgg Advances, 2022
Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes.
Kohaar I et al.
Nature Communications, 2022
Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder.
Jia X et al.
Molecular Psychiatry, 2021
Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Felicio PS et al.
Human Mutation, 2021
Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases.
Baschnagel AM et al.
Scientific Reports, 2021
Targeted Next-Generation Sequencing Indicates a Frequent Oligogenic Involvement in Primary Ovarian Insufficiency Onset.
Rossetti R et al.
Frontiers in Endocrinology, 2021
Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns.
Mateo L et al.
Genome Medicine, 2020
Germline Mutation in MUS81 Resulting in Impaired Protein Stability is Associated with Familial Breast and Thyroid Cancer.
Pinheiro M et al.
Cancers, 2020
Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer.
Torrezan GT et al.
Frontiers in Genetics, 2018
MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency.
Desai S et al.
The Journal of Clinical Endocrinology and Metabolism, 2017